Clinical Manifestations and Management of Hypophosphatemia

Definition and Classification

• Hypophosphatemia is defined as serum phosphate levels <0.81 mmol/L (<2.5 mg/dL), according to the Clinical Nutrition guidelines 1, 3
• Potentially life-threatening hypophosphatemia is defined as <1.0 mg/dL (<0.32 mmol/L) 4, 1

Neuromuscular Manifestations

• Fatigue and proximal muscle weakness are commonly observed with moderate hypophosphatemia 4
• Asthenia and myopathy can progress to respiratory failure in severe cases 4

Respiratory Manifestations

• Worsening respiratory failure is associated with hypophosphatemia 1, 3
• Increased risk of prolonged mechanical ventilation is a complication of hypophosphatemia 1, 3

Cardiovascular Manifestations

• Cardiac arrhythmias are a potential complication of hypophosphatemia 1, 3

Skeletal Manifestations

• Bone pain is a symptom of hypophosphatemia 4
• Rickets can occur in children with chronic hypophosphatemia 6, 7
• Increased risk of fractures is associated with prolonged hypophosphatemia 4

Hematologic Manifestations

• Symptoms that can mimic iron deficiency anemia are associated with hypophosphatemia 4

Other Manifestations

• Prolonged hospitalization is a potential consequence of hypophosphatemia 1, 3

Special Clinical Scenarios

• Treatment-emergent hypophosphatemia can occur after certain intravenous iron formulations, especially ferric carboxymaltose (FCM) 4
• Refeeding syndrome can trigger severe hypophosphatemia as phosphate shifts from extracellular to intracellular compartments 5
• Prevalence of hypophosphatemia is 60-80% among ICU patients 1, 3

High-Risk Populations

• Critically ill patients are at high risk of developing hypophosphatemia 1, 3
• Patients receiving kidney replacement therapy are at high risk of developing hypophosphatemia 1, 2
• Malnourished patients undergoing refeeding are at high risk of developing hypophosphatemia 5
• Patients receiving certain IV iron formulations are at high risk of developing hypophosphatemia 4
• Patients with high glomerular filtration rate are at higher risk of phosphate excretion 4

Important Caveats

• Regular monitoring of phosphate levels is crucial in high-risk patients 1, 2
• Patients with impaired kidney function have lower risk of developing hypophosphatemia due to reduced GFR 4